Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Change in Account Payables: 2019-2025

Historic Change in Account Payables for Benitec Biopharma (BNTC) over the last 7 years, with Jun 2025 value amounting to -$2.4 million.

  • Benitec Biopharma's Change in Account Payables fell 439.60% to -$5.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$2.4 million, marking a year-over-year decrease of 352.71%. This contributed to the annual value of -$2.4 million for FY2025, which is 352.71% down from last year.
  • Latest data reveals that Benitec Biopharma reported Change in Account Payables of -$2.4 million as of FY2025, which was down 352.71% from $941,000 recorded in FY2024.
  • In the past 5 years, Benitec Biopharma's Change in Account Payables registered a high of $1.4 million during FY2023, and its lowest value of -$2.4 million during FY2025.
  • For the 3-year period, Benitec Biopharma's Change in Account Payables averaged around -$26,667, with its median value being $941,000 (2024).
  • In the last 5 years, Benitec Biopharma's Change in Account Payables skyrocketed by 1,881.82% in 2022 and then crashed by 352.71% in 2025.
  • Over the past 5 years, Benitec Biopharma's Change in Account Payables (Yearly) stood at $55,000 in 2021, then skyrocketed by 1,881.82% to $1.1 million in 2022, then climbed by 24.50% to $1.4 million in 2023, then slumped by 30.66% to $941,000 in 2024, then slumped by 352.71% to -$2.4 million in 2025.